Literature DB >> 17382733

In vitro assessment of a novel dual probe ultrasonic intracorporeal lithotriptor.

Samuel C Kim1, Brian R Matlaga, William W Tinmouth, Ramsay L Kuo, Andrew P Evan, James A McAteer, James C Williams, James E Lingeman.   

Abstract

PURPOSE: The Cyberwand (Cybersonics, Erie, Pennsylvania) is a novel intracorporeal lithotrite that uses coaxial ultrasonic elements operating at 2 frequencies. We compared this device to the LithoClast(R) Ultra, which we previously noted is the most efficient commercially available intracorporeal lithotripsy device.
MATERIALS AND METHODS: An in vitro test system was used to assess the efficiency of stone penetration for the Cyberwand and the LithoClast Ultra. The devices were mounted upright with the probe tip up in a modified irrigation sheath. A gypsum artificial stone was centered on the probe tip and a mass was placed atop the stone to provide a constant force. The manufacturer recommended setting was selected for the Cyberwand, while for the LithoClast Ultra a pneumatic frequency of 12 Hz with an ultrasonic power setting of 100% was selected, representing optimal settings in previous in vitro tests. The time required for complete stone penetration was measured. Differences in mean stone penetration times were compared using ANOVA.
RESULTS: Mean +/- SD penetration time for the Cyberwand was significantly shorter than for the LithoClast Ultra (4.8 +/- 0.6 vs 8.1 +/- 0.6 seconds, p <0.0001). Neither device showed any difficulties with overheating, occlusion or another malfunction.
CONCLUSIONS: Initial assessment using our hands-free in vitro test system, in which stone penetration time is not affected by operator bias, suggests that the Cyberwand is an efficient lithotrite. These promising results justify in vivo testing.

Entities:  

Mesh:

Year:  2007        PMID: 17382733     DOI: 10.1016/j.juro.2006.11.033

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  12 in total

Review 1.  Overview of therapeutic ultrasound applications and safety considerations.

Authors:  Douglas L Miller; Nadine B Smith; Michael R Bailey; Gregory J Czarnota; Kullervo Hynynen; Inder Raj S Makin
Journal:  J Ultrasound Med       Date:  2012-04       Impact factor: 2.153

Review 2.  Ultrasound-based triggered drug delivery to tumors.

Authors:  Ankit Jain; Ankita Tiwari; Amit Verma; Sanjay K Jain
Journal:  Drug Deliv Transl Res       Date:  2018-02       Impact factor: 4.617

Review 3.  Intracorporeal lithotripsy.

Authors:  Peter Alken
Journal:  Urolithiasis       Date:  2017-12-04       Impact factor: 3.436

4.  In vitro evaluation of the Lithoclast Ultra Vario combination lithotrite.

Authors:  Jonathan N VonDerHaar; James A McAteer; James C Williams; James E Lingeman
Journal:  Urol Res       Date:  2010-10-22

5.  Outpatient tubeless percutaneous nephrolithotomy: the initial case series.

Authors:  Darren Beiko; Linda Lee
Journal:  Can Urol Assoc J       Date:  2010-08       Impact factor: 1.862

6.  New instrumentation in percutaneous nephrolithotomy.

Authors:  Joseph W Pugh; Benjamin K Canales
Journal:  Indian J Urol       Date:  2010-07

Review 7.  Role of interstitial apatite plaque in the pathogenesis of the common calcium oxalate stone.

Authors:  Andrew P Evan; James E Lingeman; Fredric L Coe; Elaine M Worcester
Journal:  Semin Nephrol       Date:  2008-03       Impact factor: 5.299

Review 8.  Surgical management of stones: new technology.

Authors:  Brian R Matlaga; James E Lingeman
Journal:  Adv Chronic Kidney Dis       Date:  2009-01       Impact factor: 3.620

9.  Consultation on kidney stones, Copenhagen 2019: lithotripsy in percutaneous nephrolithotomy.

Authors:  Tomas Andri Axelsson; Cecilia Cracco; Mahesh Desai; Mudhar Nazar Hasan; Thomas Knoll; Emanuele Montanari; Daniel Pérez-Fentes; Michael Straub; Kay Thomas; James C Williams; Marianne Brehmer; Palle J S Osther
Journal:  World J Urol       Date:  2020-07-29       Impact factor: 4.226

10.  Percutaneous nephrolithotomy: Current concepts.

Authors:  Fabio C Vicentini; Cristiano Mendes Gomes; Alexandre Danilovic; Elias A Chedid Neto; Eduardo Mazzucchi; Miguel Srougi
Journal:  Indian J Urol       Date:  2009-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.